Atlas Trials

Effects of Vitamin K on Redness Associated With Injection Site Reactions in Participants Treated With Plegridy

Clinical trial NCT03091569 · COMPLETED

Trial details

NCT number
NCT03091569
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Relapsing-Remitting Multiple Sclerosis
Start date
2017-03-10
Primary completion
2018-01-27
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.